News | Patient Positioning Radiation Therapy | September 23, 2016

ZDi Introduces Z-System Patient Positioning Devices at ASTRO 2016

Moldable technology allows more precise, reproducible positioning during treatment planning and administration

ZDi Solutions, Z-System, radiation therapy, proton therapy, patient positioning, ASTRO 2016

September 23, 2016 — ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and conventional radiation therapy facilities in the United States, with plans to collaborate worldwide. The system is comprised of the Z-Box, Z-Square and Z-Tilt. The team from ZDi will be attending the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston Sept. 25-28 to demonstrate the technology.

The devices were developed by Zachary Dutton, R.T. (R)(T), chief design officer of ZDi, who saw a need for strong, lightweight, positioning devices. Dutton explained, "Although moldable technology has improved, it can be difficult to work with as therapists navigate the positioning bag and the patient. Several hands are needed to assist in complex cases involving the thoracic and abdominal regions. A device was needed that would take the place of those extra hands. Additionally, many of these setups present a challenge for patients who are unable to hold both arms above their head."  Dutton also factored the strength of the immobilization device into his design.

The Z-Box, the custom supportive piece of the Z-System, is a winged apparatus used during immobilization foam mold fabrication, most often during computed tomography (CT) simulation. The Z-Box is fully adjustable to any arm position and has side "wings" on the board which operate on a hinge that can be raised or lowered to the desired height to fully support the patient's arms. The adjustable extension under the hands and forearms can be locked in to the appropriate height. These adjustments not only support the patient in a comfortable position but also create a deep mold for the cradle. This deep mold provides an accurate casting around the patient's arms. This exact reproducibility of the arm position is one of the most important factors in treatment alignment for proton therapy.

ZDi has successfully tested the device at the Provision Center for Proton Therapy in Knoxville, Tenn.

For more information: www.zdirad.com

Related Content

Nuclear imaging equipment growth in 2020
News | Nuclear Imaging | February 14, 2020
February 14, 2020 — The nuclear imaging equipment
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio